NYSEARCA:PRTO RCN Pareto Strategic Allocation ETF (PRTO) Price, Holdings, & News $27.65 0.00 (0.00%) As of 07/1/2026 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsRatingsBuy This Stock About RCN Pareto Strategic Allocation ETF (NYSEARCA:PRTO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PRTO alerts:Sign Up Key Stats Today's Range$27.65▼$27.6550-Day Range N/A52-Week Range$24.68▼$28.16Volume6 shsAverage VolumeN/AMarket Capitalization$613.25 millionAssets Under Management$16.78 millionDividend YieldN/ANet Expense Ratio0.82%Aggregate RatingModerate Buy ETF Overview Proteon Therapeutics was a biopharmaceutical company focused on developing treatments for patients with kidney and vascular diseases. The company’s research and development efforts centered on therapies designed to address severe and life-threatening conditions, particularly those related to renal disease and vascular access for hemodialysis patients. One of Proteon Therapeutics’ best-known product candidates was vonapanitase, an investigational enzyme developed to improve vascular access outcomes in patients with end-stage renal disease who require hemodialysis. The company evaluated the therapy in clinical studies and worked to advance it through the regulatory process, although it did not establish a broad commercial product portfolio. Proteon Therapeutics was based in the United States and operated as a clinical-stage biotechnology company. Publicly available information on the company’s leadership changed over time, and the company is best known for its development-stage pipeline rather than a large marketed business.AI Generated. May Contain Errors. Read More RCN Pareto Strategic Allocation ETF ExpensesTypePRTOAsset Allocation ETFsMulti Asset ETFsNYSEARCA ETFsAll ETFsManagement Fee0.69%0.63%0.71%0.51%0.53%Other Expenses0.13%0.32%0.68%0.58%0.55%Total Expense0.82%0.86%1.16%0.74%0.73%Fee Waiver0.00%-0.17%-0.52%-0.70%-0.62%Net Expense0.82%0.79%0.97%0.58%0.60% Receive PRTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RCN Pareto Strategic Allocation ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRTO ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com PRTO ETF - Frequently Asked Questions How have PRTO shares performed this year? RCN Pareto Strategic Allocation ETF's stock was trading at $27.56 on June 29, 2026. Since then, PRTO stock has increased by 0.3% and is now trading at $27.65. How do I buy shares of RCN Pareto Strategic Allocation ETF? Shares of PRTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerTidal ETF Services Fund NameRCN Pareto Strategic Allocation ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PRTO Inception Date3/25/2026 Fund ManagerNick Lumpp, Quinn Berry, Scott Snyder WebN/A PhoneN/AFund Focus Asset ClassMulti Asset BenchmarkN/A CategoryStrategy FocusAsset Allocation Development LevelBlended Development RegionGlobal Number of Holdings20 Fund Statistics Assets Under Management$16.78 million Average Daily Volume$0.00 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorTidal ETF Services, LLC AdvisorTidal Investments, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerJane Street Miscellaneous Outstanding Shares22,179,000Beta0.60 Creation Fee$300.00 10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report Top 10 PRTO HoldingsSchwab US Small-Cap ETF (NYSEARCA:SCHA)Holding Weight: 22.38%iShares Russell 2000 ETF (NYSEARCA:IWM)Holding Weight: 22.03%abrdn Physical Gold Shares ETF (NYSEARCA:SGOL)Holding Weight: 11.69%Invesco QQQ (NASDAQ:QQQ)Holding Weight: 7.92%State Street® SPDR® S&P 500® ETFHolding Weight: 7.57%SPDR Gold MiniShares Trust (NYSEARCA:GLDM)Holding Weight: 6.53%Schwab US Dividend Equity ETF (NYSEARCA:SCHD)Holding Weight: 5.00%Simplify Managed Futures Strategy ETF (NYSEARCA:CTA)Holding Weight: 3.29%Technology Select Sector SPDR Fund (NYSEARCA:XLK)Holding Weight: 2.55%Vanguard Total International Stock ETF (NASDAQ:VXUS)Holding Weight: 2.52%Full Holdings DetailsPRTO Sector ExposurePRTO Industry Exposure This page (NYSEARCA:PRTO) was last updated on 7/2/2026 by MarketBeat.com Staff. From Our PartnersDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredUrgent exposé on the "Mar-a-Lago Trade"Dr. David Eifrig, former Goldman Sachs VP and Senior Partner at Stansberry Research, has released an urgent ex...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredThe startup growing 23 times faster than NvidiaAn official SEC document contains a name Elon Musk revealed on page 146 - a startup that one analyst believes ...Brownstone Research | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredGold Is About to Do Something It Hasn’t in 90 YearsThe U.S. Treasury still carries America's gold reserves at $42 per ounce — a price set generations ago. Buried...US Gold Bureau | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RCN Pareto Strategic Allocation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share RCN Pareto Strategic Allocation ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
